11. SEGMENTS (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Revenues	$ 4,656,550	$ 3,399,401	$ 8,698,556	$ 6,028,272
Cost of product revenue	9,645,662	4,334,019	21,888,410	5,950,306
Loss from operations	(13,417,381)	(8,401,868)	(29,949,884)	(14,338,871)
Interest and other expense, net	(1,330,450)	(634,627)	(2,620,089)	(1,234,587)
Net loss	(14,747,831)	(9,036,495)	(32,569,973)	(15,573,458)
Total assets	117,751,992	84,639,253
Depreciation and amortization expense	845,899	277,132	1,675,439	395,194
Capital expenditures			1,046,375	96,557
ADMA BioManufacturing
Revenues	2,144,724	539,223	3,810,967	539,223
Cost of product revenue	7,965,681	2,498,856	18,663,323	2,498,856
Loss from operations	(9,918,243)	(3,118,300)	(22,642,709)	(3,118,300)
Interest and other expense, net	(237,161)	(61,987)	(477,214)	(61,987)
Net loss	(10,155,404)	(3,180,287)	(23,119,923)	(3,180,287)
Total assets	54,297,915	65,913,839
Depreciation and amortization expense	639,300	158,398	1,271,131	158,398
Capital expenditures			591,665	0
Plasma Collection Center Member
Revenues	2,476,117	2,824,469	4,816,172	5,417,632
Cost of product revenue	1,679,981	1,835,163	3,225,087	3,451,450
Loss from operations	(941,993)	(610,864)	(1,980,817)	(1,113,464)
Interest and other expense, net	(436)	0	(871)	0
Net loss	(942,429)	(610,864)	(1,981,688)	(1,113,464)
Total assets	5,438,645	2,101,977
Depreciation and amortization expense	200,598	103,703	389,512	207,343
Capital expenditures			454,710	81,294
Corporate Member
Revenues	35,709	35,709	71,417	71,417
Cost of product revenue	0	0	0	0
Loss from operations	(2,557,145)	(4,672,704)	(5,326,358)	(10,107,107)
Interest and other expense, net	(1,092,853)	(572,640)	(2,142,004)	(1,172,600)
Net loss	(3,649,998)	(5,245,344)	(7,468,362)	(11,279,707)
Total assets	58,015,432	16,623,437
Depreciation and amortization expense	$ 6,001	$ 15,031	14,796	29,453
Capital expenditures			$ 0	$ 15,263